Cambium Bio Limited
CMB
Kedudukan dalam Saham
#32554
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Harga Saham
$0.31737816
Disegerakkan terakhir: 2026-10-18
Modal Pasaran
$9.34M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
5,917.33%
Negara
AU
Perdagangan Cambium Bio Limited (CMB)
Kategori
Healthcare
Modal pasaran bagi Cambium Bio Limited(CMB)
Modal Pasaran: $9.34M
Sehingga October 2026, Cambium Bio Limited mempunyai modal pasaran sebanyak $9.34M. Ini menjadikan Cambium Bio Limited syarikat ke-32554th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Cambium Bio Limited dari 2013 hingga 2026
CMB berbanding dengan 5 teratas yang paling popular stocks
